Volume 97, Issue 9

Search all Annals of Hematology articles

September 2018

33 articles in this issue

Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis
Yangmin Zhu
Qingyan Gao
Fengkui Zhang
Review Article 26 June 2018 Pages: 1519 - 1526
Copper deficiency anemia: review article
Zin W. Myint
Thein H. Oo
Hayder Saeed
Review Article 29 June 2018 Pages: 1527 - 1534
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
Yoshihiro Hatta
Shuichi Mizuta
Tomoki Naoe
Original Article Open access 24 April 2018 Pages: 1535 - 1545
The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
Yan Hong
Xiaosu Zhao
Xiaojun Huang
Original Article 28 April 2018 Pages: 1547 - 1554
Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins
Alfonso Vignoli
Marina Marchetti
Anna Falanga
Original Article 01 May 2018 Pages: 1555 - 1562
Distinctive CD8⁺ T cell and MHC class I signatures in polycythemia vera patients
Elsa M. Cardoso
André J. Esgalhado
Fernando A. Arosa
Original Article 22 May 2018 Pages: 1563 - 1575
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
Massimo Breccia
Elisabetta Abruzzese
Robin Foà
Original Article 19 April 2018 Pages: 1577 - 1580
The WHO diagnostic criteria for polycythemia vera—role of red cell mass versus hemoglobin/hematocrit level and morphology
Ljubomir Jakovic
Mirjana Gotic
Jürgen Thiele
Original Article 01 May 2018 Pages: 1581 - 1590
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial
Martin Griesshammer
Guray Saydam
Francesco Passamonti
Original Article Open access 27 May 2018 Pages: 1591 - 1600
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence
Corentin Orvain
Francois Beloncle
Aline Tanguy-Schmidt
Original Article 02 May 2018 Pages: 1601 - 1609
The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders
Satoshi Takanashi
Tomonori Nakazato
Takehiko Mori
Original Article 30 April 2018 Pages: 1611 - 1618
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
Chiara Ciochetto
Barbara Botto
Umberto Vitolo
Original Article 16 April 2018 Pages: 1619 - 1626
Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature
Nyanza K. L. M. Timmers
Josanne S. de Maar
Saskia K. Klein
Original Article Open access 29 April 2018 Pages: 1627 - 1632
Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma
Marc Sorigue
Francisco Gual-Capllonch
Juan-Manuel Sancho
Original Article 04 May 2018 Pages: 1633 - 1640
Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease
Yujun Dong
Lu Zhang
Jian Li
Original Article 07 May 2018 Pages: 1641 - 1647
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients
Eric P. Allain
Karin Venzl
Katrina Vanura
Original Article Open access 21 May 2018 Pages: 1649 - 1661
A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion
Yuqing Miao
Yi Miao
Jian-Yong Li
Original Article 07 May 2018 Pages: 1663 - 1669
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
Eirini Katodritou
Marie-Christine Kyrtsonis
Evangelos Terpos
Original Article Open access 13 May 2018 Pages: 1671 - 1682
− 174 G>C IL-6 polymorphism and primary iron overload in male patients
Walter F. Tetzlaff
Tomás Meroño
Fernando Brites
Original Article 14 April 2018 Pages: 1683 - 1687
Efficacy of decitabine as hemoglobin F inducer in HbE/β-thalassemia
Siddhesh Arun Kalantri
Rudra Ray
Maitreyee Bhattacharyya
Original Article 09 May 2018 Pages: 1689 - 1694
Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A
Hyun-Young Kim
Jin-Hee Cho
Hee-Jin Kim
Original Article 16 May 2018 Pages: 1695 - 1700
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation
Mingming Qu
Qiang Liu
A. J. Gerard Jansen
Original Article Open access 18 May 2018 Pages: 1701 - 1706
Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies
Bernard Tawfik
Larry Brown
Navid Sadeghi
Original Article 21 April 2018 Pages: 1707 - 1716
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
C. Cattaneo
R. Di Blasi
on behalf of SEIFEM Group
Original Article 28 April 2018 Pages: 1717 - 1726
Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?
Narendranath Epperla
Ariel Kleman
Patrick Foy
Letter to the Editor 14 April 2018 Pages: 1727 - 1729
SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation
Jieun Kim
In Sik Hwang
Seung-Tae Lee
Letter to the Editor 12 April 2018 Pages: 1731 - 1734
Mott cell interstitial nephritis revealing Waldenström macroglobulinaemia
Anissa Moktefi
Caroline Dudreuilh
Philippe Rémy
Letter to the Editor 08 April 2018 Pages: 1735 - 1736
Copper deficiency: a cause of misdiagnosis of myelodysplastic syndrome
Ana Villalba
Julieta Osorio
Leonor Senent
Letter to the Editor 17 April 2018 Pages: 1737 - 1738
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to l-asparaginase
Junko Watanabe
Shinichi Makita
Koji Izutsu
Letter to the Editor 16 April 2018 Pages: 1739 - 1740
Massive hemolysis complicating acute granulomatous hepatitis
Adrià Carpio
Anna Merino
Javier Fernández
Letter to the Editor 19 April 2018 Pages: 1741 - 1742
Correction to: The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study
Zara Forbrigger
Stefan Kuhle
Ketan Kulkarni
Correction 27 June 2018 Pages: 1743 - 1743
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
Alexander Egle
Michael Steurer
Richard Greil
Correction 23 June 2018 Pages: 1745 - 1745
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
Eirini Katodritou
Marie-Christine Kyrtsonis
Evangelos Terpos
Correction 26 June 2018 Pages: 1747 - 1747

Volume 97, Issue 9

Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis

Copper deficiency anemia: review article

Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL

The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins

Distinctive CD8⁺ T cell and MHC class I signatures in polycythemia vera patients

Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice

The WHO diagnostic criteria for polycythemia vera—role of red cell mass versus hemoglobin/hematocrit level and morphology

Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial

Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence

The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders

Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience

Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature

Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients

A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

− 174 G>C IL-6 polymorphism and primary iron overload in male patients

Efficacy of decitabine as hemoglobin F inducer in HbE/β-thalassemia

Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A

Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation

Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies

Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria

Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?

SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation

Mott cell interstitial nephritis revealing Waldenström macroglobulinaemia

Copper deficiency: a cause of misdiagnosis of myelodysplastic syndrome

Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to l-asparaginase

Massive hemolysis complicating acute granulomatous hepatitis

Correction to: The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Navigation